Ronald Goldblum

1.3k total citations · 1 hit paper
10 papers, 964 citations indexed

About

Ronald Goldblum is a scholar working on Genetics, Immunology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ronald Goldblum has authored 10 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Immunology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ronald Goldblum's work include Inflammatory Bowel Disease (3 papers), Acute Lymphoblastic Leukemia research (2 papers) and Pain Mechanisms and Treatments (2 papers). Ronald Goldblum is often cited by papers focused on Inflammatory Bowel Disease (3 papers), Acute Lymphoblastic Leukemia research (2 papers) and Pain Mechanisms and Treatments (2 papers). Ronald Goldblum collaborates with scholars based in United States, France and Australia. Ronald Goldblum's co-authors include Remo Panaccione, William J. Sandborn, Stephan R. Targan, Gary S. Hogge, Paul Rutgeerts, Stephen B. Hanauer, Sander van Deventer, Stefan Schreiber, Brian G. Feagan and Jean‐Frédéric Colombel and has published in prestigious journals such as New England Journal of Medicine, Annals of the New York Academy of Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

Ronald Goldblum

10 papers receiving 920 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

2005 688 citations William J. Sandborn, Jean‐Frédéric Colombel et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ronald Goldblum United States	8	672	492	340	142	110	10	964
Rasha Aguzzi United States	10	387 0.6×	324 0.7×	583 1.7×	131 0.9×	166 1.5×	23	1.2k
Tamsanqa Hove Netherlands	5	294 0.4×	181 0.4×	258 0.8×	83 0.6×	68 0.6×	5	576
Ping Wei China	10	220 0.3×	102 0.2×	371 1.1×	79 0.6×	47 0.4×	14	714
K.‐H. Meyer zum Büschenfelde Germany	13	82 0.1×	220 0.4×	136 0.4×	61 0.4×	27 0.2×	44	582
Amir Karban Israel	9	444 0.7×	246 0.5×	237 0.7×	240 1.7×	37 0.3×	18	849
Gheorghe Hundorfean Germany	13	224 0.3×	147 0.3×	364 1.1×	88 0.6×	26 0.2×	24	787
Z Awdeh United States	8	175 0.3×	46 0.1×	448 1.3×	100 0.7×	162 1.5×	14	726
Bernice Lo United States	16	216 0.3×	84 0.2×	519 1.5×	78 0.5×	65 0.6×	30	796
Georgia Fousteri Italy	18	408 0.6×	56 0.1×	562 1.7×	234 1.6×	31 0.3×	50	978
Yannick Simoni Singapore	16	296 0.4×	110 0.2×	822 2.4×	181 1.3×	28 0.3×	28	1.2k

Countries citing papers authored by Ronald Goldblum

Since Specialization

Citations

This map shows the geographic impact of Ronald Goldblum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Goldblum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Goldblum more than expected).

Fields of papers citing papers by Ronald Goldblum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Goldblum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Goldblum. The network helps show where Ronald Goldblum may publish in the future.

Co-authorship network of co-authors of Ronald Goldblum

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Goldblum. A scholar is included among the top collaborators of Ronald Goldblum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Goldblum. Ronald Goldblum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Schiff, Michael, Johannes von Kempis, Ronald Goldblum, John Tesser, & Ruediger B. Müeller. (2014). Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase. Annals of the Rheumatic Diseases. 73(12). 2174–2177. 37 indexed citations

Sands, Bruce E., Richard A. Kozarek, Charles F. Barish, et al.. (2006). Safety and tolerability of concurrent natalizumab treatment for patients with Crohnʼs disease not in remission while receiving infliximab. Inflammatory Bowel Diseases. 13(1). 2–11. 149 indexed citations

Sandborn, William J., Jean‐Frédéric Colombel, Brian G. Feagan, et al.. (2005). Natalizumab Induction and Maintenance Therapy for Crohn's Disease. New England Journal of Medicine. 353(18). 1912–1925. 688 indexed citations breakdown →

Grundy, John S., Subra Kugathasan, Deborah Hilton, et al.. (2005). PHARMACOKINETICS AND PHARMACODYNAMICS OF NATALIZUMAB IN A PHASE 2 STUDY OF ADOLESCENT PATIENTS WITH CROHN'S DISEASE. Journal of Pediatric Gastroenterology and Nutrition. 41(4). 538–538. 7 indexed citations

Goldblum, Ronald. (2000). Long-Term Safety of MorphiDex®. Journal of Pain and Symptom Management. 19(1). 50–56. 8 indexed citations

Caruso, Frank, et al.. (2000). Dextromethorphan, an NMDA-receptor antagonist, enhances the analgesic properties of morphine. Inflammopharmacology. 8(2). 161–173. 4 indexed citations

Portenoy, Russell K., Augusto Caraceni, Nathan I. Cherny, et al.. (1999). Dynorphin A(1-13) Analgesia in Opioid-Treated Patients with Chronic Pain. Clinical Drug Investigation. 17(1). 33–42. 11 indexed citations

Angst, Martin S., John B. Dyck, Daniel L. Azarnoff, et al.. (1998). Pharmacokinetics, cortisol release, and hemodynamics after intravenous and subcutaneous injection of human corticotropin-releasing factor in humans*. Clinical Pharmacology & Therapeutics. 64(5). 499–510. 4 indexed citations

Goldblum, Ronald, et al.. (1995). In vivo and in vitro evaluation of four different aqueous polymeric dispersions for producing an enteric coated tablet. International Journal of Pharmaceutics. 115(1). 29–34. 8 indexed citations

10.

Talal, Norman, Michael J. Dauphinée, Rao J. Pillarisetty, & Ronald Goldblum. (1975). EFFECT OF THYMOSIN ON THYMOCYTE PROLIFERATION AND AUTOIMMUNITY IN NZB MICE. Annals of the New York Academy of Sciences. 249(1). 438–450. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact